Provided by Tiger Trade Technology Pte. Ltd.

Agenus

9.61
-0.3227-3.25%
Volume:123.26K
Turnover:1.20M
Market Cap:432.52M
PE:3.84
High:9.95
Open:9.95
Low:9.56
Close:9.93
52wk High:10.31
52wk Low:2.71
Shares:45.02M
Float Shares:40.38M
Volume Ratio:1.51
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.50
EPS(LYR):-0.0034
ROE:-1278.83%
ROA:12.53%
PB:-2.17
PE(LYR):-2,829.00

Loading ...

Agenus Tunjuk Marco Tullio Marcucci Sebagai Direktur Baru Dewan Komisaris

Reuters
·
Aug 12

Agenus Price Target Cut to $25.00/Share from $30.00 by HC Wainwright & Co.

Dow Jones
·
Aug 11

Agenus Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 08

Agenus Files for Resale of Up to 78 Million Shares

MT Newswires Live
·
Aug 08

Agenus - Offers up to 77,976,718 Shares of Common Stock by Selling Securityholders - SEC Filing

THOMSON REUTERS
·
Aug 08

Xenetic Biosciences Q2 Royalty Revenue Rises on Takeda Sublicense

Reuters
·
Aug 07

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 07

Agenus Q2 Revenue Rises on Access and Royalty Income

Reuters
·
Aug 06

Agenus Swings to Q2 FY26 Net Loss of $0.6 Million; Revenue Rises 34.24% to $34.5 Million Year-over-Year

Reuters
·
Aug 06

Agenus Q2 Sales $34.500M Beat $34.000M Estimate

Benzinga Earnings
·
Aug 06

Agenus Q2 Operating Income USD 11.3 Million

Reuters
·
Aug 06

Agenus Reports Second Quarter 2026 Results and Advances Phase 3 Robbin Trial of BOT+Bal in Neoadjuvant Mss Colon Cancer

THOMSON REUTERS
·
Aug 06

Agenus - BOT+Bal Access Programs Contribute $6.40 Mln in Q2 Pre-Commercial Product Revenue

THOMSON REUTERS
·
Aug 06

Agenus Q2 Net Income USD -600 Thousand

THOMSON REUTERS
·
Aug 06

Press Release: Agenus Reports Second Quarter 2026 Results and Advances Phase 3 Robbin Trial of Bot+bal in Neoadjuvant MSS Colon Cancer

Dow Jones
·
Aug 06

Agenus Inc Expected to Post Earnings of 5 Cents a Share - Earnings Preview

Reuters
·
Aug 04

B. Riley Adjusts Agenus Price Target to $14 From $8, Maintains Buy Rating

MT Newswires Live
·
Jul 30

Agenus Posts Corporate Presentation Spotlighting Botensilimab-balstilimab Neoadjuvant Strategy in MSS Colon Cancer

Reuters
·
Jul 30

Agenus Inc : B. Riley Raises Target Price to $14 from $8

THOMSON REUTERS
·
Jul 30

U.S. Research ROUNDUP-Equinix, Meta, S&P Global

Reuters
·
Jul 30